About Privi Life Sciences Private Limited
Data last updated: 27 February 2026
Privi Life Sciences Private Limited is a private limited company based in Thane, Maharashtra, India. It specialises in fertilizers and soil enhancers, a part of the broader agriculture sector. Incorporated on 29 June 1990, the company has been in operation for over 36 years.
Registered with ROC Mumbai under CIN U24239MH1990PTC057075.
Capital: an authorised share capital of ₹50 Cr and a paid-up capital of ₹40.01 Cr. Formerly known as Privi Pharma Private Limited. It is led by directors including Vinaykumar Doppalapudi Rao and Rajesh Harichandra Budhrani.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: A – 71 Ground Floor Privi House Ttc Thane Belapur Road, Near Kopar Khairane Railway Station Navi Mumbai, Maharashtra, India – 400710.
As per the financials filed for FY 2025, the company reported a revenue of ₹102.89 Cr, a growth of 6.85% compared to the previous year.
The company has a workforce of approximately 173 employees as per the latest available data.
As per MCA filings, the company has open charges of ₹80 Cr and satisfied charges of ₹17.58 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website privilifesciences.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered AddressA – 71 Ground Floor Privi House Ttc Thane Belapur Road, Near Kopar Khairane Railway Station Navi Mumbai, Maharashtra, India – 400710
-
IndustryAgriculture, Fertilizers & Soil Enhancers, Livestock & Husbandry
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Business Activity of Privi Life Sciences Private Limited
Privi Life Sciences Private Limited operates primarily in the manufacturing sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Manufacturing | ********* | chemical products Manufacture of chemicals and | ********* |
Auditor Details of Privi Life Sciences Private Limited
Privi Life Sciences Private Limited is audited by GMJ & Co. for the financial year 2025. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| GMJ & Co. | blur-value | blur-value | blur-value |
Board of Directors of Privi Life Sciences Private Limited
Privi Life Sciences Private Limited is currently managed by 4 directors, with 18 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinaykumar Doppalapudi Rao | Director | 26 Sep 2009 | 16 Years 9 Months | Current |
| Rajesh Harichandra Budhrani | Director | 05 Apr 2022 | 4 Years 3 Months | Current |
|
Rajan Sundar Ramakrishnan
Also directs:
Livpure Smart Homes Private Limited, Livpure Private Limited
|
Director | 23 Jun 2017 | 9 Years 0 Months | Current |
|
Anoop Purshotam Babani
Also directs:
Privi Associates Limited Liability Partnership, Satguru Ventures 7-12 Llp, Babani Brothers Llp and 2 more
|
Director | 21 Dec 2016 | 9 Years 6 Months | Current |
Financials of Privi Life Sciences Private Limited FY 2025 filings available
Privi Life Sciences Private Limited reported revenue of ₹101.15 Cr (up 6.85% YoY) for FY 2025. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Privi Life Sciences Private Limited
As of FY 2025, Privi Life Sciences Private Limited's shareholding pattern shows 67.77% by promoters, 27.41% by public shareholders, 1.50% by others. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings of Privi Life Sciences Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Dec 2022 | Hdfc Bank Limited | ₹30 Cr | Open |
| 28 Apr 2021 | Hdfc Bank Limited | ₹10 Cr | Open |
| 16 Apr 2021 | Hdfc Bank Limited | ₹40 Cr | Open |
| 17 Jul 2020 | Others | ₹63.98 Lakh | Satisfied |
| 07 Jul 2020 | Others | ₹32.6 Lakh | Satisfied |
Total charge records: 15 View all charges
Employees and EPFO Compliance at Privi Life Sciences Private Limited
Privi Life Sciences Private Limited has a workforce of 173 employees as of Sep 26, 2025.
Employee Count & EPFO Data of Privi Life Sciences Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Privi Life Sciences Private Limited
GSTIN & GST Filing Data of Privi Life Sciences Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Privi Life Sciences Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Privi Life Sciences Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Privi Life Sciences Private Limited
MSME Payment Delays by Privi Life Sciences Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Privi Life Sciences Private Limited
Subsidiaries & Group Companies of Privi Life Sciences Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Privi Life Sciences Private Limited with ownership details.
MCA Filings & Documents of Privi Life Sciences Private Limited
MCA Filings & Documents of Privi Life Sciences Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Privi Life Sciences Private Limited
Frequently Asked Questions about Privi Life Sciences Private Limited
Privi Life Sciences Private Limited is an active private limited company in the agriculture sector based in Thane, Maharashtra, India. It was incorporated on 29 June 1990 (36+ years old) and is registered under CIN U24239MH1990PTC057075. The company has 173 employees.
Privi Life Sciences Private Limited reported revenue of ₹102.89 Cr for FY 2025 (up 6.85% YoY).
The current directors of Privi Life Sciences Private Limited are:
The primary industry of Privi Life Sciences Private Limited is agriculture. The company specifically operates in fertilizers and soil enhancers. The company is currently active in this sector.
Privi Life Sciences Private Limited can be reached at the registered office: A – 71 Ground Floor Privi House Ttc Thane Belapur Road, Near Kopar Khairane Railway Station Navi Mumbai, Maharashtra, India – 400710, or through the website privilifesciences.com.
The authorised capital is ₹50 Cr, and the paid-up capital is ₹40.01 Cr.